Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInventory AverageNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Sales

Avricore Health (AVCRF) EBIT Margin (2016 - 2025)

Historic EBIT Margin for Avricore Health (AVCRF) over the last 16 years, with Q3 2025 value amounting to 1012.72%.

  • Avricore Health's EBIT Margin fell 9980800.0% to 1012.72% in Q3 2025 from the same period last year, while for Sep 2025 it was 44.36%, marking a year-over-year decrease of 466400.0%. This contributed to the annual value of 2.7% for FY2024, which is 225900.0% up from last year.
  • Latest data reveals that Avricore Health reported EBIT Margin of 1012.72% as of Q3 2025, which was down 9980800.0% from 1651.97% recorded in Q2 2025.
  • Avricore Health's EBIT Margin's 5-year high stood at 16.9% during Q1 2023, with a 5-year trough of 1651.97% in Q2 2025.
  • Over the past 5 years, Avricore Health's median EBIT Margin value was 32.07% (recorded in 2022), while the average stood at 254.73%.
  • As far as peak fluctuations go, Avricore Health's EBIT Margin surged by 8719900bps in 2022, and later tumbled by -16571400bps in 2025.
  • Over the past 5 years, Avricore Health's EBIT Margin (Quarter) stood at 161.24% in 2021, then surged by 85bps to 24.43% in 2022, then soared by 121bps to 5.07% in 2023, then grew by 27bps to 6.44% in 2024, then tumbled by -15837bps to 1012.72% in 2025.
  • Its last three reported values are 1012.72% in Q3 2025, 1651.97% for Q2 2025, and 17.48% during Q1 2025.